KLIFS - the structural kinase database

Searching for structures with analogs of Vandetanib.

Search results (35 entries covering 26 PDB structures)

Kinase	Family	Group	PDB	Chain	(Alternate) Model	Orthosteric ligand	Organism	Details	Similarity (MFP)
EGFR	EGFR	TK	4i23	A		(2e)-n-{4-[(3-chloro-4-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}-4-(piperidin-1-yl)but-2-enamide	Human	870	0.40
MERTK (MER)	Axl	TK	7avy	A		n-(2-(2-cyclopropylethoxy)pyrimidin-5-yl)-7-methoxy-6-(piperidin-4-ylmethoxy)quinazolin-4-amine	Human	13369	0.47
EGFR	EGFR	TK	7a6j	A	B	1-[4-[4-[[3,4-bis(chloranyl)-2-fluoranyl-phenyl]amino]-7-methoxy-quinazolin-6-yl]oxypiperidin-1-yl]propan-1-one	Human	14124	0.46
EGFR	EGFR	TK	3ug2	A	A	gefitinib	Human	898	0.47
EGFR	EGFR	TK	4i24	A		(2e)-n-{4-[(3-chloro-4-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}-4-(piperidin-1-yl)but-2-enamide	Human	831	0.40
CDK2	CDK	CMGC	1di8	A		4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline	Human	4577	0.41
EGFR	EGFR	TK	4i22	A		gefitinib	Human	823	0.47
EGFR	EGFR	TK	2ity	A		gefitinib	Human	790	0.47
EGFR	EGFR	TK	4wkq	A	A	gefitinib	Human	889	0.47
EGFR	EGFR	TK	4wkq	A	B	gefitinib	Human	837	0.47
GAK	NAK	Other	5y7z	B		gefitinib	Human	10331	0.47
EGFR	EGFR	TK	9ou9	A		4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl (2r)-2,4-dimethylpiperazine-1-carboxylate	Human	15880	0.46
ILK	MLK	TKL	9d5h	A		gefitinib	Human	15989	0.47
ILK	MLK	TKL	9d5e	A		gefitinib	Human	15992	0.47
EGFR	EGFR	TK	8f1y	A		1-[4-[4-[[3,4-bis(chloranyl)-2-fluoranyl-phenyl]amino]-7-methoxy-quinazolin-6-yl]oxypiperidin-1-yl]propan-1-one	Human	14940	0.46
EGFR	EGFR	TK	8f1w	A		1-[4-[4-[[3,4-bis(chloranyl)-2-fluoranyl-phenyl]amino]-7-methoxy-quinazolin-6-yl]oxypiperidin-1-yl]propan-1-one	Human	14944	0.46
EGFR	EGFR	TK	3ug2	A	B	gefitinib	Human	819	0.47
EGFR	EGFR	TK	2ito	A		gefitinib	Human	783	0.47
EGFR	EGFR	TK	2itz	A		gefitinib	Human	789	0.47
MAPK14 (p38a)	MAPK	CMGC	1di9	A		4-[3-methylsulfanylanilino]-6,7-dimethoxyquinazoline	Human	5251	0.42
EGFR	EGFR	TK	7a6j	A	A	1-[4-[4-[[3,4-bis(chloranyl)-2-fluoranyl-phenyl]amino]-7-methoxy-quinazolin-6-yl]oxypiperidin-1-yl]propan-1-one	Human	14125	0.46
EPHB4 (EphB4)	Eph	TK	2vwu	A		n-(5-chloro-1,3-benzodioxol-4-yl)-6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-amine	Human	370	0.40
EGFR	EGFR	TK	7u9a	A		4-(5-chloro-4-fluoro-2-hydroxyanilino)-7-methoxyquinazolin-6-ol	Human	14527	0.41
GAK	NAK	Other	5y80	A	A	gefitinib	Human	10329	0.47
GAK	NAK	Other	5y80	A	B	gefitinib	Human	10330	0.47
GAK	NAK	Other	5y7z	A		gefitinib	Human	10332	0.47
KSR2	RAF	TKL	5kkr	B		6,7-dimethoxy-~{n}-(2-methyl-4-phenoxy-phenyl)quinazolin-4-amine	Human	7027	0.42
TTBK1	TTBK	CK1	4btk	A		4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline	Human	771	0.41
RET	Ret	TK	5amn	A		4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline	Human	6412	0.41
RET	Ret	TK	2ivu	A		4-bromo-2-fluoro-n-[(4e)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4(1h)-ylidene]aniline	Human	3364	1.00
EGFR	EGFR	TK	4i24	B		(2e)-n-{4-[(3-chloro-4-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}-4-(piperidin-1-yl)but-2-enamide	Human	910	0.40
TTBK2	TTBK	CK1	6u0k	B	A	4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline	Human	12049	0.41
TTBK2	TTBK	CK1	6u0k	A	A	4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline	Human	12046	0.41
TTBK2	TTBK	CK1	6u0k	B	B	4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline	Human	12047	0.41
TTBK2	TTBK	CK1	6u0k	A	B	4-[3-hydroxyanilino]-6,7-dimethoxyquinazoline	Human	12048	0.41